AnalystsJonathan ChangJonathan Chang's Stock Forecasts
AnalystsJonathan Chang
Analyst Ranking
Bottom 3%
#4454 out of 4554 analysts
Average Return
-21.89%
Win Rate
24%17 out of 71
Risk vs Reward
Poor
Good
Jonathan Chang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mersana Therapeutics IncMRSN | +133.33% | $3.18 | $7.42 | 2022-05-08 - 2023-05-08 | Buy |
Fusion Pharmaceuticals IncFUSN | +110.13% | $2.27 | $4.77 | 2022-11-29 - 2023-11-29 | Buy |
Point Biopharma Global IncPNT | +100.44% | $6.81 | $13.65 | 2022-11-29 - 2023-11-29 | Buy |
Zai Lab LtdZLAB | +85.12% | $74.00 | $136.99 | 2020-09-09 - 2021-09-09 | Buy |
Mersana Therapeutics IncMRSN | +57.36% | $3.87 | $6.09 | 2022-02-17 - 2023-02-17 | Buy |
Jonathan Chang Analyst Color
Get additional color on Jonathan Chang's coverage of popular stocks
Jonathan Chang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nanobiotix SaNBTX | 1 | Buy | $11.00 | +100.00% | Initiates Coverage On | 4 months ago |
Novocure LtdNVCR | 1 | Buy | $51.00 | +323.24% | Initiates Coverage On | 8 months ago |
Karyopharm Therapeutics IncKPTI | 9 | Hold | $5.00 | N/A | Maintains | a year ago |
Replimune Group IncREPL | 9 | Buy | $34.00 | N/A | Maintains | a year ago |
Fusion Pharmaceuticals IncFUSN | 1 | Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Point Biopharma Global IncPNT | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Calithera Biosciences IncCALA | 6 | Hold | $2.00 | N/A | Downgrades | a year ago |
Harpoon Therapeutics IncHARP | 4 | Buy | $40.00 | N/A | Maintains | a year ago |
Genmab AGMAB | 9 | Hold | $33.00 | N/A | Maintains | a year ago |
Tcr2 Therapeutics IncTCRR | 7 | Hold | $2.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 4 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Vincerx Pharma IncVINC | 5 | Buy | $5.00 | N/A | Maintains | 2 years ago |
Revolution Medicines IncRVMD | 3 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Macrogenics IncMGNX | 5 | Buy | $12.00 | N/A | Maintains | 2 years ago |
Rubius Therapeutics IncRUBY | 6 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Mersana Therapeutics IncMRSN | 5 | Buy | $14.00 | N/A | Maintains | 2 years ago |
Immatics NvIMTX | 5 | Buy | $26.00 | N/A | Maintains | 2 years ago |
Zai Lab LtdZLAB | 8 | Buy | $95.00 | N/A | Maintains | 2 years ago |
Athenex IncATNXQ | 5 | Hold | $60.00 | N/A | Maintains | 2 years ago |
Adaptimmune Therapeutics PLCADAP | 6 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Immunogen IncIMGN | 3 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Kura Oncology IncKURA | 3 | Buy | $28.00 | N/A | Maintains | 2 years ago |
Xencor IncXNCR | 3 | Buy | $53.00 | N/A | Maintains | 3 years ago |
Armo Biosciences IncARMO | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.